Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Lidocaine Hydrochloride Patent Expiration

Lidocaine Hydrochloride is Used for providing local anesthesia with the delivery of powdered lidocaine hydrochloride monohydrate. It was first introduced by Fresenius Kabi Usa Llc in its drug Xylocaine on Approved Prior to Jan 1, 1982. Other drugs containing Lidocaine Hydrochloride are Xylocaine Dental, Lidocaine Hydrochloride 0.4% In Dextrose 5% In Plastic Container, Xylocaine 1.5% W/ Dextrose 7.5%, Xylocaine 5% W/ Glucose 7.5%, Lidocaine Hydrochloride Preservative Free, Xylocaine 4% Preservative Free, Lidocaine Hydrochloride 0.4% And Dextrose 5% In Plastic Container, Zingo, Lidocaine Hydrochloride 0.2% In Dextrose 5% In Plastic Container, Lidocaine Hydrochloride, Lidocaine Hydrochloride 0.8% And Dextrose 5% In Plastic Container, Lidocaine Hydrochloride 0.8% In Dextrose 5% In Plastic Container, Akten, Xylocaine Viscous, Xylocaine Preservative Free, Lidocaine Hydrochloride 0.1% And Dextrose 5% In Plastic Container, Lidocaine Hydrochloride 0.2% And Dextrose 5% In Plastic Container, Lidopen. 53 different companies have introduced drugs containing Lidocaine Hydrochloride.


Lidocaine Hydrochloride Patents

Given below is the list of patents protecting Lidocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zingo US9370622 Devices and methods for delivering particles Sep 28, 2035 Powder Pharms
Zingo US9358338 Particle cassettes and processes therefor Apr 27, 2035 Powder Pharms
Zingo US8540665 Particle cassettes and processes therefor Oct 22, 2029 Powder Pharms
Akten US8759401 Aqueous gel formulation and method for inducing topical anesthesia Jul 24, 2026 Thea Pharma
Zingo US6004286 Particle delivery Mar 17, 2017

(Expired)

 Powder Pharms
Zingo US6881200 Needleless syringe using super sonic gas flow for particle delivery Jun 11, 2016

(Expired)

 Powder Pharms
Zingo US5899880 Needleless syringe using supersonic gas flow for particle delivery May 04, 2016

(Expired)

 Powder Pharms
Zingo US5630796 Method of delivering powder transdermally with needless injector May 20, 2014

(Expired)

 Powder Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lidocaine Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Lidocaine Hydrochloride.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed
Critical
 12 Feb, 2024 US9370622
Payment of Maintenance Fee, 8th Yr, Small Entity 05 Mar, 2021 US8540665
Payment of Maintenance Fee, 4th Yr, Small Entity 03 Jul, 2019 US9370622
Recordation of Patent Grant Mailed
Critical
 21 Jun, 2016 US9370622
Patent Issue Date Used in PTA Calculation
Critical
 21 Jun, 2016 US9370622
Issue Notification Mailed
Critical
 01 Jun, 2016 US9370622
Dispatch to FDC 24 May, 2016 US9370622
Application Is Considered Ready for Issue
Critical
 20 May, 2016 US9370622
Issue Fee Payment Verified
Critical
 20 May, 2016 US9370622
Issue Fee Payment Received
Critical
 20 May, 2016 US9370622


Lidocaine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lidocaine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Lidocaine Hydrochloride. The first generic version for Lidocaine Hydrochloride was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by The J Molner Co Ou and was approved on Apr 29, 2024.

Given below is the list of companies who have filed for Lidocaine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. ABBOTT

Abbott Laboratories Hosp Products Div has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Out of these 2% version comes by the name PEDIATRIC LTA KIT. Given below are the details of the strengths of this generic introduced by Abbott.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10%

injectable Discontinued INJECTION N/A Feb 2, 1983
2%

solution Discontinued TOPICAL N/A Jul 31, 1984
20%

injectable Discontinued INJECTION N/A May 25, 1988


Manufacturing Plant Locations
New

Abbott's manufacturing plants are situated in 7 countries - United States, Netherlands, United Kingdom, Norway, Germany, France, Ireland. Given below are the details of these plant locations as well as the firm names of Abbott as present at those locations.

Country City Firm Name
United States
Alameda Abbott Diabetes Care, Inc.
Scarborough Abbott Diagnostics Scarborough, Inc.
Plymouth Abbott
Barceloneta Abbott Healthcare (Puerto Rico) Ltd.
Clearwater ABBOTT BLACKSTONE CO.
Barceloneta Abbott Diagnostics International, Ltd.
Netherlands
Olst Abbott Biologicals BV
United Kingdom
Witney ABBOTT DIABETES CARE LIMITED
Norway
Oslo Abbott Diagnostics Technologies AS
Germany
Wiesbaden Abbott GmbH
France
Chatillon Sur Chalaronne Abbott Healthcare SAS
Ireland
Sligo Abbott Ireland Limited
Sligo Abbott Ireland
Cootehill ABBOTT IRELAND LIMITED
Donegal ABBOTT IRELAND DIABETES CARE
Co. Longford Abbott Ireland Diagnostics Division





2. ABRAXIS PHARM

Abraxis Pharmaceutical Products has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
1.5%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





3. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name LIDOCAINE HYDROCHLORIDE VISCOUS. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

solution Discontinued ORAL N/A Approved Prior to Jan 1, 1982





4. AFAXYS

Afaxys Pharma Llc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Afaxys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Jun 9, 2022





5. AM REGENT

American Regent Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Am Regent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Aug 14, 2015





6. ASPIRO

Aspiro Pharma Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Nov 8, 2021
2%

injectable Prescription INJECTION AP Dec 13, 2023


Manufacturing Plant Locations
New

Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.

Country City Firm Name
India
Siddipet (Dist) Aspiro Pharma Limited





7. B BRAUN MEDICAL INC

B Braun Medical Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by B Braun Medical Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Aug 3, 2018


Manufacturing Plant Locations
New

B Braun Medical Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of B Braun Medical Inc as present at those locations.

Country City Firm Name
United States
Breinigsville B Braun Medical Inc





8. BEL MAR

Bel Mar Laboratories Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Bel Mar.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





9. BELMORA LLC

Belmora Llc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Belmora Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Belmora Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Belmora Llc as present at those locations.

Country City Firm Name
United States
Arlington Belmora LLC





10. BIONPHARMA

Bionpharma Inc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name ANESTACON. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

jelly Discontinued TOPICAL N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





11. CARLISLE

Carlisle Laboratories Inc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name ALPHACAINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Carlisle.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Carlisle's manufacturing plants are situated in 2 countries - United States, China. Given below are the details of these plant locations as well as the firm names of Carlisle as present at those locations.

Country City Firm Name
United States
Carlisle Carlisle Regional Medical Center
Kent Carlisle Interconnect Technolog
China
Dongguan CARLISLE MEDICAL TECHNOLOGIES(DONGGUAN) CO., LTD





12. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name LIDOCAINE HYDROCHLORIDE VISCOUS. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

solution Prescription ORAL AT Feb 27, 2007





13. COSETTE

Cosette Pharmaceuticals Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

jelly Discontinued TOPICAL N/A Apr 29, 1993


Manufacturing Plant Locations
New

Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.

Country City Firm Name
United States
South Plainfield Cosette Pharmaceuticals, Inc.
Lincolnton Cosette Pharmaceuticals NC Laboratories, LLC





14. DELL LABS

Dell Laboratories Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dell Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





15. ELKINS SINN

Elkins Sinn Div Ah Robins Co Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Elkins Sinn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
0.5%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





16. EPIC PHARMA LLC

Epic Pharma Llc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





17. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

injectable Prescription INJECTION AP Oct 30, 2017
1%

injectable Prescription INJECTION AP Oct 30, 2017


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Riico Industrial Area EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited





18. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Out of these 1% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Jul 24, 1985
2%

injectable Prescription INJECTION AP Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC





19. GD SEARLE LLC

Gd Searle Llc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Gd Searle Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





20. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Out of these 1% version comes by the name LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Approved Prior to Jan 1, 1982
2%

solution Discontinued ORAL N/A Jul 10, 1995
4%

(reference standard)

solution Prescription TOPICAL AT Apr 3, 1985


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





21. HOSPIRA

Hospira Inc has filed for 10 different strengths of generic version for Lidocaine Hydrochloride. Out of these 1% version comes by the name LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, 1.5% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, 4% version comes by the name LTA II KIT, 2% version comes by the name LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, 20% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, 200mg/100ml version comes by the name LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%, 400mg/100ml version comes by the name LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%, 5% version comes by the name LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, 0.5% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, 10% version comes by the name LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Sep 28, 1998
1.5%

injectable Discontinued INJECTION N/A Jul 31, 1984
4%

solution Discontinued TOPICAL N/A Jul 31, 1984
2%

injectable Prescription INJECTION AP Sep 28, 1998
20%

injectable Discontinued INJECTION N/A Jul 31, 1984
200MG/100ML

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
400MG/100ML

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
5%

(reference standard)

injectable Prescription SPINAL N/A Approved Prior to Jan 1, 1982
0.5%

injectable Prescription INJECTION AP Jul 31, 1984
10%

injectable Discontinued INJECTION N/A Jul 31, 1984


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Lake Forest Hospira Inc
Clayton Hospira, Inc.
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Morgan Hill Hospira Inc
Mcpherson Hospira, Inc., A Pfizer Company
Rocky Mount Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





22. HUONS

Huons Co Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Huons.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP May 7, 2020
2%

injectable Prescription INJECTION AP Jun 15, 2023


Manufacturing Plant Locations
New

Huons's manufacturing plants are situated in 1 country - Korea (the Republic of). Given below are the details of these plant locations as well as the firm names of Huons as present at those locations.

Country City Firm Name
Korea (the Republic of)
Jecheon Huons Co., Ltd. - Jecheon Factory





23. INTL MEDICATION

International Medication Systems Ltd has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Out of these 2% version comes by the name LIDOCAINE HYDROCHLORIDE VISCOUS, 4% version comes by the name LARYNG-O-JET KIT. Given below are the details of the strengths of this generic introduced by Intl Medication.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Approved Prior to Jan 1, 1982
2%

solution Discontinued ORAL N/A Feb 2, 1982
4%

solution Prescription TOPICAL AT Approved Prior to Jan 1, 1982





24. KENDALL IL

Kendall Co has filed for 1 generic for Lidocaine Hydrochloride. This 4% version comes by the name LARYNGOTRACHEAL ANESTHESIA KIT. Given below are the details of the strengths of this generic introduced by Kendall Il.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

solution Discontinued TOPICAL N/A Jun 10, 1983





25. LANNETT CO INC

Lannett Co Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

solution Prescription TOPICAL AT Feb 27, 2007





26. LUITPOLD

Luitpold Pharmaceuticals Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Luitpold.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





27. LYPHOMED

Lyphomed Div Fujisawa Usa Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lyphomed.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





28. MANKIND PHARMA

Mankind Pharma Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Mankind Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Nov 29, 2023
2%

injectable Prescription INJECTION AP Jul 11, 2023


Manufacturing Plant Locations
New

Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.

Country City Firm Name
India
Imt Manesar Mankind Pharma Limited
Paonta Sahib Mankind Pharma Limited





29. MILES

Miles Laboratories Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Miles.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Miles's manufacturing plants are situated in 3 countries - United States, India, Spain. Given below are the details of these plant locations as well as the firm names of Miles as present at those locations.

Country City Firm Name
United States
Roseland Milestone Scientific, Inc.
Baxley Miles Berry Farm Inc.
San Antonio Milestone Surgical LLC
Los Angeles Miles Produce Inc
Baxley Miles Sunbelt Blueberry Corporation
Ekron Miles Farm Center
India
Krishna District Milesh Marine Exports Pvt. Ltd.
Spain
Gijon MILESMAN S.L.





30. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

solution Prescription TOPICAL AT Mar 23, 2022


Manufacturing Plant Locations
New

Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.

Country City Firm Name
United States
East Windsor Novitium Pharma LLC





31. PACO

Paco Research Corp has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Paco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

solution Discontinued TOPICAL N/A Jun 30, 1989


Manufacturing Plant Locations
New

Paco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Paco as present at those locations.

Country City Firm Name
United States
Navassa Pacon Manufacturing Corporation
New Orleans Pacorini Logistics, LLC
Friona PACO Feed Yard,LLC





32. PAI HOLDINGS PHARM

Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Out of these 2% version comes by the name LIDOCAINE HYDROCHLORIDE VISCOUS. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

solution Prescription TOPICAL AT Mar 12, 2014
2%

solution Prescription ORAL AT Feb 20, 2024





33. PHARMATON

Pharmaton Ltd has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name LIDOCATON. Given below are the details of the strengths of this generic introduced by Pharmaton.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

injectable Discontinued INJECTION N/A Aug 17, 1983





34. RISING

Rising Pharma Holding Inc has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

injectable Discontinued INJECTION N/A Apr 11, 2014
0.5%

injectable Discontinued INJECTION N/A Dec 8, 2010
1%

injectable Discontinued INJECTION N/A Dec 8, 2010


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Phoenix Rising Sun Farms Inc
Fort Bragg Rising Tide Sea Vegetables
Saddle Brook Rising Pharmaceuticals, Inc.
Decatur Rising Pharma Holdings, Inc
Livingston Risingsun Iodine Products Corp.
East Brunswick Rising Pharma Holding, Inc.
Mount Morris Rising Creek Bakery LLC
Rising Sun Rising Sun Veterinary Clinic
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





35. RUBICON

Rubicon Research Private Ltd has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rubicon.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

(reference standard)

solution Prescription ORAL AT Mar 28, 2023


Manufacturing Plant Locations
New

Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.

Country City Firm Name
United States
Indianapolis Rubicon Foods LLC
Geismar Rubicon, LLC
Canada
Concord Rubicon Research Canada Limited
India
Ambarnath Rubicon Research Private Limited





36. SAGENT PHARMS INC

Sagent Pharmaceuticals Inc has filed for 1 generic for Lidocaine Hydrochloride. This 2% version comes by the name GLYDO. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

(reference standard)

jelly Prescription TOPICAL AT Apr 28, 2014





37. SENTISS

Sentiss Ag has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sentiss.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

jelly Prescription TOPICAL AT Feb 12, 2003


Manufacturing Plant Locations
New

Sentiss's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Sentiss as present at those locations.

Country City Firm Name
India
District Solan Sentiss Pharma Pvt. Ltd.





38. SINTETICA US

Sintetica Us Llc has filed for 3 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sintetica Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

injectable Prescription INJECTION AP May 5, 2022
2%

injectable Prescription INJECTION AP Sep 19, 2022
1%

injectable Prescription INJECTION AP Sep 19, 2022





39. SPECTRA MDCL DEVICES

Spectra Medical Devices Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Spectra Mdcl Devices.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Apr 18, 2018





40. TARO

Taro Pharmaceuticals Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

solution Prescription TOPICAL AT Dec 7, 2023


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Honolulu Taro Delight, LLC
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





41. THE J MOLNER

The J Molner Co Ou has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by The J Molner.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4%

solution Prescription TOPICAL AT Apr 29, 2024





42. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





43. WATSON LABS INC

Watson Laboratories Inc has filed for 1 generic for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

jelly Discontinued TOPICAL N/A Mar 23, 2011





44. WEST-WARD PHARMS INT

West-ward Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Prescription INJECTION AP Approved Prior to Jan 1, 1982
2%

injectable Prescription INJECTION AP Approved Prior to Jan 1, 1982





45. WOCKHARDT BIO AG

Wockhardt Bio Ag has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2%

solution Prescription ORAL AT Nov 18, 1982
4%

solution Prescription TOPICAL AT Nov 18, 1982





46. WYETH AYERST

Wyeth Ayerst Laboratories has filed for 2 different strengths of generic version for Lidocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wyeth Ayerst.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982